Oracit (CMP Pharma, Inc.)
Welcome to the PulseAid listing for the Oracit drug offered from CMP Pharma, Inc.. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | CMP Pharma, Inc. |
| NON-PROPRIETARY NAME: | Citric Acid and Sodium Citrate |
| SUBSTANCE NAME: | CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 1984-05-15 |
| END MARKETING DATE: | 0000-00-00 |
Oracit HUMAN PRESCRIPTION DRUG Details:
| Item Description | Oracit from CMP Pharma, Inc. |
| LABELER NAME: | CMP Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 640; 490(mg/5mL; mg/5mL) |
| START MARKETING DATE: | 1984-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 46287-014_30162932-ce96-42ad-b1be-46c636668a2f |
| PRODUCT NDC: | 46287-014 |
| APPLICATION NUMBER: | |
Other CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
